These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6795228)

  • 1. Stimulation of growth hormone release by vasoactive intestinal polypeptide from human pituitary adenomas in vitro.
    Matsushita N; Kato Y; Katakami H; Shimatsu A; Yanaihara N; Imura H
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1297-300. PubMed ID: 6795228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vasoactive intestinal polypeptide on growth hormone secretion in perifused acromegalic pituitary adenoma tissues.
    Chihara K; Iwasaki J; Minamitani N; Kaji H; Matsukura S; Tamaki N; Matsumoto S; Fujita T
    J Clin Endocrinol Metab; 1982 Apr; 54(4):773-9. PubMed ID: 6120948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
    Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
    Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characterization of the stimulant effect of 2 neuropeptides (thyroliberin (TRH) and vasoactive intestinal peptide (VIP)) on the secretion of the growth hormone in the rat].
    Durand D; Bluet-Pajot MT; Mounier F; Leonard JF; Pressac M
    Reprod Nutr Dev (1980); 1987; 27(2B):481-9. PubMed ID: 3114836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
    Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
    Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.
    Le Dafniet M; Lefebvre P; Barret A; Mechain C; Feinstein MC; Brandi AM; Peillon F
    J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effect of dopamine on growth hormone (GH) release from human GH-secreting pituitary adenomas.
    Spada A; Sartorio A; Bassetti M; Pezzo G; Giannattasio G
    J Clin Endocrinol Metab; 1982 Oct; 55(4):734-40. PubMed ID: 7107817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.
    Hofland LJ; van Koetsveld PM; van Vroonhoven CC; Stefanko SZ; Lamberts SW
    J Clin Endocrinol Metab; 1989 Mar; 68(3):613-20. PubMed ID: 2493040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly.
    Chihara K; Kaji H; Minamitani N; Kodama H; Kita T; Goto B; Chiba T; Coy DH; Fujita T
    J Clin Endocrinol Metab; 1984 Jan; 58(1):81-6. PubMed ID: 6417157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
    Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
    J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of VIP, TRH, GABA and dopamine on prolactin release from superfused rat anterior pituitary cells.
    Matsushita N; Kato Y; Shimatsu A; Katakami H; Yanaihara N; Imura H
    Life Sci; 1983 Mar; 32(11):1263-9. PubMed ID: 6132313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly.
    Watanobe H; Tamura T
    Neuropeptides; 1995 Feb; 28(2):115-24. PubMed ID: 7746355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies on prolactin release and adenylate cyclase activity in human prolactin-secreting pituitary adenomas. Different sensitivity of macro- and microadenomas to dopamine and vasoactive intestinal polypeptide.
    Spada A; Nicosia S; Cortelazzi L; Pezzo G; Bassetti M; Sartorio A; Giannattasio G
    J Clin Endocrinol Metab; 1983 Jan; 56(1):1-10. PubMed ID: 6292253
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
    Aizawa T; Hinkle PM
    Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.